-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Disc Medicine, Lowers Price Target to $125

Benzinga·02/17/2026 15:40:50
Listen to the news
Cantor Fitzgerald analyst Kristen Kluska maintains Disc Medicine (NASDAQ:IRON) with a Overweight and lowers the price target from $153 to $125.